Kurse werden geladen...
Prognose
Für dieses Unternehmen liegen uns keine Analysten-Daten vor.
Scoring-Modelle
Für dieses Unternehmen liegen uns bisher keine Scoring-Modelle vor.
News
VERAXA Biotech to Attend Key Industry Conferences to Showcase BiTAC Technology Platform
VERAXA Attending ASCO and BIO with Cantor Fitzgerald, Voyager's Recently Retained Capital Markets Advisor, and Hosting Meetings with Potential Partners and Investors VERAXA Attending ASCO and BIO with Cantor Fitzgerald, Voyager's Recently Retained Capital Markets Advisor, and Hosting Meetings with Potential Partners and Investors» Mehr auf globenewswire.com
VERAXA Biotech to Attend Key Industry Conferences to Showcase BiTAC Technology Platform
VERAXA Attending ASCO and BIO with Cantor Fitzgerald, Voyager's Recently Retained Capital Markets Advisor, and Hosting Meetings with Potential Partners and Investors VERAXA Attending ASCO and BIO with Cantor Fitzgerald, Voyager's Recently Retained Capital Markets Advisor, and Hosting Meetings with Potential Partners and Investors» Mehr auf globenewswire.com
VERAXA Biotech Appoints Rick Austin as Chief Scientific Officer
Industry Veteran to Support Acceleration of Key Pipeline Projects and Novel BiTAC™ Antibody Formats Towards Clinical Studies Industry Veteran to Support Acceleration of Key Pipeline Projects and Novel BiTAC™ Antibody Formats Towards Clinical Studies» Mehr auf globenewswire.com
Unternehmenszahlen
| (EUR) | März 2025 | |
|---|---|---|
| Umsatz | 0,00 | - |
| Bruttoeinkommen | 0,00 | - |
| Nettoeinkommen | 2,25 Mio | 4.764,35% |
| EBITDA | −244,96k | 408,02% |
Fundamentaldaten
| Metrik | Wert |
|---|---|
Marktkapitalisierung | 285,01 Mio€ |
Anzahl Aktien | 31,63 Mio |
52 Wochen-Hoch/Tief | 9,73€ - 8,64€ |
| Dividenden | Nein |
Beta | 0 |
KGV (PE Ratio) | 39,61 |
KGWV (PEG Ratio) | 0,97 |
KBV (PB Ratio) | −22,57 |
KUV (PS Ratio) | 0,00 |
Unternehmensprofil
| Name | Voyager Acquisition Corp Class A Ordinary Shares |
| CEO | Adeel Rouf Ennis |
| Mitarbeiter | 0 |
Assets entdecken
Shareholder von Voyager Acquisition Corp Class A Ordinary Shares investieren auch in folgende Assets
